Fact-checked by Grok 2 weeks ago

Biochemical engineering

Biochemical engineering is a subdiscipline of chemical engineering that applies principles from biology, chemistry, mathematics, and physics to design, develop, and optimize processes involving biological systems, such as microorganisms, enzymes, and cells, for the production of valuable products like pharmaceuticals, biofuels, and biomaterials.^[1]^[2] This field focuses on the commercialization of biotechnology by integrating engineering methodologies with biochemical reactions to achieve efficient, scalable bioprocesses.^[1] The discipline traces its origins to the 1940s, when large-scale microbial fermentation processes were developed for antibiotic production, such as penicillin, to meet wartime demands.^[3] Over the decades, it has evolved alongside advancements in molecular biology, including genetic engineering and synthetic biology, enabling precise manipulation of biological pathways for industrial applications.^[3]^[1] Key principles include bioprocess kinetics, bioreactor design for optimal cell growth and product yield, downstream separation techniques, and metabolic engineering to enhance organism performance.^[1] These foundational elements ensure the economic viability and sustainability of biological production systems. Biochemical engineering plays a pivotal role in addressing global challenges, with major applications in biopharmaceutical manufacturing (e.g., therapeutic proteins and vaccines), bioenergy production (e.g., biofuels from algae or waste), environmental remediation (e.g., bioremediation of pollutants), and food and agriculture (e.g., enzyme-based processing).^[3]^[1] Notable advancements include strain engineering for higher yields, such as increasing lipid content in microalgae by up to 35% for biodiesel, and the development of cell-free systems for scalable synthesis.^[1] Looking forward, the field emphasizes sustainable practices, such as using non-model organisms and hybrid bio-chemical processes, to support personalized medicine and circular economies.^[3]

Fundamentals

Definition and Scope

Biochemical engineering is defined as the application of chemical engineering principles to biological systems, utilizing living organisms, enzymes, or biological molecules to design, develop, and optimize processes for producing valuable products such as pharmaceuticals, biofuels, and enzymes.^[4] This field extends traditional chemical engineering by incorporating biological catalysts—such as microbes, cells, or immobilized enzymes—to achieve desired chemical transformations in aqueous environments, often under mild conditions like pH 6–8 and temperatures of 15–40°C.^[5] The discipline emerged in the 1940s, rooted in efforts to scale up antibiotic production, marking the integration of biology with engineering for industrial applications.^[4] The scope of biochemical engineering encompasses the integration of biological sciences— including microbial fermentation, cellular metabolism, and enzymatic reactions—with engineering fundamentals such as thermodynamics, kinetics, and transport phenomena to enable scalable biomanufacturing.^[6] Central to this scope are unit operations like bioconversion, where substrates are transformed into products via biological pathways, and bioseparation, which involves purifying biomolecules from complex mixtures, often requiring multiple steps due to low product concentrations (e.g., 100 mg/L) and product instability.^[5] This interdisciplinary approach addresses challenges in translating laboratory-scale biological discoveries into efficient, commercial processes, emphasizing reactor design, process modeling, and downstream recovery to handle dilute and labile biological materials.^[4] The primary objectives of biochemical engineering are to enhance process efficiency by maximizing product yield and purity while promoting sustainability through reduced energy use and waste generation in biomanufacturing.^[4] For instance, engineers optimize conditions to improve overall recovery rates, which can be as low as 10–20%, and economic viability for end products like antibiotics, vaccines, and therapeutics, ensuring they meet regulatory standards for scalability and environmental impact.^[5] These goals distinguish biochemical engineering from pure biotechnology, which primarily focuses on genetic manipulation and molecular innovations, whereas biochemical engineering prioritizes the engineering of process scale-up, integration, and optimization for industrial production.^[5]

Key Principles and Concepts

Biochemical engineering applies core chemical engineering principles, such as thermodynamics, fluid dynamics, and heat and mass transfer, to biological systems involving living cells and enzymes, enabling the design and optimization of processes that harness biological reactions for industrial production.^[4] These principles are adapted to account for the dynamic and heterogeneous nature of biological media, where reactions occur in complex, often multiphase environments influenced by cellular metabolism.^[4] A fundamental concept is microbial growth kinetics, which quantifies how microbial populations expand in bioprocesses. The specific growth rate (μ) is defined by the equation

\mu = \frac{1}{X} \frac{dX}{dt}

where X represents biomass concentration and t is time, providing a measure of growth per unit biomass.^[7] This rate often follows models like the Monod equation, linking growth to substrate availability, but the basic definition underpins quantitative predictions of biomass accumulation in fermentations.^[7] Stoichiometry in bioprocesses describes the quantitative relationships between substrates, biomass, products, and byproducts, extending chemical reaction balances to account for cellular needs. Yield coefficients, such as the biomass yield on substrate Y_{X/S} (grams of biomass produced per gram of substrate consumed), capture the efficiency of resource conversion, typically ranging from 0.1 to 0.5 g/g depending on the organism and conditions.^[8] Maintenance energy concepts further refine these balances, recognizing that a portion of substrate is diverted to non-growth activities like cell repair and motility, modeled by a maintenance coefficient (m) in equations like the substrate consumption rate

q_s = \frac{\mu}{Y_{X/S}^\max} + m

, where

Y_{X/S}^\max

is the true growth-associated yield.^[9] This distinction explains why observed yields decrease at low growth rates, guiding process efficiency assessments.^[9] Enzymatic reaction kinetics form another cornerstone, modeling how biocatalysts accelerate transformations in bioprocesses. The Michaelis-Menten equation describes the initial reaction velocity (v) as

v = \frac{V_{\max} [S]}{K_m + [S]}

where V_{\max} is the maximum velocity, [S] is substrate concentration, and K_m is the Michaelis constant indicating substrate affinity.^[10] Inhibition models extend this framework; for competitive inhibition, the apparent K_m increases to K_m (1 + [I]/K_i), where [I] is inhibitor concentration and K_i is the inhibition constant, allowing prediction of reduced rates in the presence of product or substrate analogs.^[11] Non-competitive inhibition affects V_{\max} instead, highlighting enzyme flexibility in complex media.^[11] Transport phenomena are critical in biological media, where diffusion and convection govern nutrient and product distribution. Oxygen transfer, essential for aerobic processes, is quantified by the oxygen transfer rate (OTR):

\text{OTR} = k_L a (C^* - C)

with k_L a as the volumetric mass transfer coefficient (often 50–500 h⁻¹ in bioreactors), C^* as the saturation concentration, and C as the dissolved oxygen level, ensuring sufficient supply to prevent growth limitations.^[12] Similar principles apply to other solutes, integrating fluid dynamics to scale processes effectively.^[12] Sterility and contamination control are paramount, as bioprocesses rely on maintaining pure cultures to avoid yield losses or safety issues. Aseptic operations involve designing equipment with smooth surfaces, steam sterilization, and HEPA filtration to minimize microbial ingress, achieving contamination rates below 0.1% in validated systems.^[13] Validation protocols, including media fills and environmental monitoring, ensure process integrity throughout.^[13]

Historical Development

Origins in Chemical and Biological Engineering

Biochemical engineering originated from the convergence of chemical engineering principles and microbiological insights during the late 19th and early 20th centuries, transforming empirical biological processes into systematic industrial practices. Its foundational roots lie in 19th-century studies of fermentation, exemplified by Louis Pasteur's 1857 experiments demonstrating that yeast cells drive alcoholic fermentation through a biological process rather than a spontaneous chemical reaction. This work shifted understanding from mystical or chemical explanations of fermentation to a microbial basis, laying the groundwork for controlled bioprocessing.^[14] Pasteur's discoveries emphasized the role of living organisms in biochemical transformations, influencing later efforts to scale such processes industrially.^[5] Parallel developments in chemical engineering provided the engineering framework for handling biological materials. In 1915, Arthur D. Little formalized the concept of unit operations, proposing that chemical processes could be broken down into fundamental steps like distillation, filtration, and evaporation, independent of specific substances. This approach enabled chemical engineers to apply standardized methods to diverse feedstocks, including biological ones, facilitating the adaptation of fermentation outputs to industrial scales.^[15] Concurrently, Emil Fischer's enzyme research in the 1890s advanced the biochemical understanding essential for engineering applications; his 1894 lock-and-key hypothesis explained enzyme-substrate specificity, providing a molecular rationale for catalytic efficiency in biological reactions.^[16] The field began to coalesce as a distinct discipline in the 1920s and 1930s through industrial microbiology, spurred by wartime needs. During World War I, the demand for acetone—used in cordite production—led to the commercialization of microbial fermentation processes, notably Chaim Weizmann's 1916 development of the acetone-butanol-ethanol (ABE) fermentation using Clostridium acetobutylicum to convert starch into solvents at scale. This marked one of the first large-scale bioprocesses engineered for chemical output, blending microbiological cultivation with chemical engineering separations. Chemical engineers like George G. Brown contributed by refining unit operations for bio-derived products; his 1932 textbook Unit Operations detailed distillation and extraction techniques adaptable to volatile fermentation byproducts, bridging empirical brewing traditions with scientific design.^[17]^[18] These efforts established biochemical engineering's interdisciplinary core, evolving from ad-hoc distilleries and breweries toward rigorous bioprocessing by the late 1930s.^[14]

Major Milestones and Advances

One of the earliest major milestones in biochemical engineering occurred during World War II, when Pfizer developed large-scale deep-tank fermentation for penicillin production. In 1944, under the leadership of chemical engineer Jasper Kane, Pfizer scaled up production using submerged fermentation in massive stainless-steel tanks, transitioning from laboratory-scale batches to industrial volumes exceeding 28,000 liters per tank, which enabled the company to supply over 90% of the penicillin used by Allied forces on D-Day.^[19]^[20] This breakthrough not only addressed wartime shortages but also established fermentation as a cornerstone of bioprocess engineering, paving the way for antibiotic manufacturing on a global scale.^[19] The 1970s marked a transformative era with the integration of recombinant DNA technology into biochemical engineering. In 1973, biochemists Herbert Boyer and Stanley Cohen demonstrated the first successful gene cloning by inserting DNA from one bacterium into another, creating recombinant organisms capable of producing novel proteins.^[21] This innovation directly enabled the engineering of microbes for human insulin production; by 1978, Genentech produced the first recombinant insulin using Escherichia coli, culminating in the FDA's approval of Humulin in 1982 as the inaugural biotechnology-derived therapeutic.^[22]^[23] These advances shifted biochemical engineering from traditional fermentation to genetically modified bioprocesses, revolutionizing pharmaceutical production.^[21] During the 1980s and 1990s, bioreactor design saw significant innovations that enhanced efficiency and scalability in biochemical processes. Airlift bioreactors, which use gas sparging for mixing without mechanical agitators, gained prominence for shear-sensitive cultures, with key patents and implementations emerging in the mid-1980s to support aerobic fermentations.^[24] Concurrently, membrane bioreactor systems advanced, integrating ultrafiltration or microfiltration for simultaneous reaction and separation, particularly in the late 1980s and 1990s, improving product recovery and reducing contamination in biopharmaceutical applications.^[25] These developments were complemented by the completion of the Human Genome Project in 2003, which provided comprehensive genomic data that accelerated metabolic engineering by enabling pathway modeling and targeted modifications in microbial hosts for optimized bioproduct yields.^[26] In the 21st century, biochemical engineering benefited from breakthroughs in genome editing and sustainable bioprocessing. The 2012 introduction of CRISPR-Cas9 by Jennifer Doudna and Emmanuelle Charpentier offered precise, efficient tools for modifying microbial genomes, facilitating rapid strain engineering for enhanced enzyme production and metabolic flux in industrial bioprocesses.^[27] Around the same time, sustainable bioenergy advanced with U.S. Department of Energy-funded demonstration plants for cellulosic ethanol; in 2007, initiatives like Range Fuels' Soperton facility broke ground as the first commercial-scale plant converting lignocellulosic biomass to ethanol, demonstrating scalable hydrolysis and fermentation integration.^[28]^[29] A notable recent milestone occurred during the COVID-19 pandemic (2020–2021), when biochemical engineers rapidly scaled up mRNA vaccine production for platforms like the Pfizer-BioNTech and Moderna vaccines. This involved optimizing bioreactor systems and downstream purification to manufacture billions of doses within months, showcasing advancements in continuous bioprocessing and lipid nanoparticle formulation for global distribution.^[30]^[31] Regulatory frameworks also evolved to support these innovations, with the FDA issuing its 1996 guidance on "Demonstration of Comparability of Human Biological Products, Including Therapeutic Biotechnology-derived Products," which standardized validation protocols for manufacturing changes in biopharmaceuticals, ensuring safety and efficacy during process scale-up and modifications.^[32] This document provided critical guidelines for comparability studies, bolstering confidence in engineered bioprocesses and facilitating industry adoption.^[32]

Bioprocess Design and Engineering

Upstream Processes: Fermentation and Bioreactors

Upstream processes in biochemical engineering focus on the cultivation of microorganisms or cells to generate biomass or bioproducts, primarily through controlled fermentation in bioreactors that optimize growth conditions such as nutrient availability, aeration, and environmental parameters. These stages set the foundation for bioprocess efficiency by maximizing yield and productivity before downstream recovery. Bioreactors serve as the core hardware, enabling precise manipulation of biological reactions while integrating engineering principles like mass transfer and kinetics.^[33] Fermentation modes are selected based on process goals, with batch, fed-batch, and continuous operations being predominant. Batch fermentation involves adding all media upfront, allowing growth until nutrient exhaustion or inhibition, as demonstrated in Escherichia coli insulin production reaching 2 g/L over 24 hours.^[33] Fed-batch extends this by intermittent or continuous nutrient feeding to sustain metabolism and avoid overflow, evident in Pichia pastoris antibody yields of 7 g/L through controlled glycerol and methanol addition.^[33] Continuous fermentation maintains steady-state dynamics via constant inflow of fresh media and outflow of culture, typically in chemostat systems where the dilution rate balances growth. The steady-state design equation for a chemostat is D = \mu - k_d, where D (s⁻¹) is the dilution rate (volumetric flow rate divided by reactor volume), \mu (s⁻¹) is the specific growth rate, and k_d (s⁻¹) is the cell death rate constant; in ideal cases without decay (k_d = 0), D = \mu prevents washout while controlling biomass.^[34] Bioreactor configurations are tailored to reaction kinetics and organism needs, with the stirred-tank reactor (STR), functioning as a continuous stirred-tank reactor (CSTR), being ubiquitous for its uniform mixing via impellers and effective gas dispersion through spargers, scaling to 10,000–20,000 L for microbial cultures.^[35] Packed-bed bioreactors immobilize biocatalysts on fixed supports to facilitate plug-flow conditions, ideal for immobilized cell systems like enzyme production.^[36] Fluidized-bed bioreactors suspend particulate media in an upward fluid stream, promoting high mass transfer rates in aerobic processes such as wastewater treatment.^[36] Scale-up from lab to production maintains process similarity using criteria like constant power input per unit volume (P/V = constant), which preserves turbulent mixing and oxygen transfer; for instance, scaling from 1 L to 100 L demands approximately 100-fold higher power while ensuring hydrodynamic consistency.^[37] Media formulation underpins upstream success by supplying essential nutrients balanced for growth and product formation. Carbon sources, such as glucose at 10–20 g/L, provide energy and building blocks for E. coli, while nitrogen sources like ammonium chloride or urea at 1–2 g/L support protein synthesis in Bacillus subtilis.^[33] Environmental controls maintain pH at 5.5–7.0 (e.g., 7.0 for E. coli) and temperature in the 25–37°C range optimal for most mesophilic microbes, aligning with enzyme kinetics and preventing thermal stress.^[33] Inoculum preparation scales starter cultures progressively, starting with 5–10 mL of nutrient broth for E. coli to achieve 10⁸ cells/mL before inoculation into larger vessels, ensuring rapid initiation without contamination.^[33] Cell harvesting targets the exponential growth phase for maximal viability, such as at optical density 0.6 for enzyme-producing E. coli, using centrifugation or filtration post-fermentation.^[33] Effective monitoring and control systems employ inline sensors to track key variables and sustain performance. Dissolved oxygen (DO) sensors maintain levels at 20–50% air saturation to support aerobic respiration, with biomass indirectly assessed via optical density or dielectric spectroscopy.^[38] pH electrodes enable real-time adjustments via acid or base dosing to stabilize at setpoints like 7.0–7.4.^[38] Oxygen limitation is averted through sparging (injecting air/O₂ mixtures below impellers) combined with agitation speeds of 100–500 rpm, which disperses bubbles and enhances transfer coefficients without excessive shear.^[38] Genetic engineering integrates into upstream design for strain optimization, particularly via overexpression of biosynthetic pathways to boost flux and titers. Techniques like CRISPR-mediated multi-loci editing in Saccharomyces cerevisiae enable coordinated gene amplification and promoter strengthening, yielding up to 4-fold higher recombinant protein secretion in fed-batch cultures.^[39] Such modifications, including codon optimization, target rate-limiting steps to enhance metabolic efficiency without compromising cell viability.^[39]

Downstream Processes: Separation and Purification

Downstream processes in biochemical engineering encompass the unit operations designed to recover, isolate, purify, and concentrate biological products from complex fermentation broths or cell cultures, often representing 50-80% of total bioprocessing costs due to the need for high purity and yield.^[40] These operations must address the dilute nature of products (typically 1-10% of total solids) while preserving bioactivity, with typical overall recovery yields ranging from 50-90% depending on the product complexity.^[41] Key challenges include maintaining product stability under varying pH, temperature, and shear conditions, as well as removing impurities like host cell proteins, endotoxins, and viruses to meet regulatory standards.^[42] Centrifugation serves as a primary solid-liquid separation step to remove cells and debris, enhancing clarification efficiency through enhanced gravitational forces. The performance is quantified by the sigma factor (Σ), which represents the equivalent settling area under gravity, given for tubular bowls as \Sigma = \frac{\pi L \omega^2 (r_2^2 - r_1^2)}{g \ln(r_2 / r_1)}, where L (m) is the effective bowl length, \omega is angular velocity, r is radius, and g is gravitational acceleration; this allows scaling by maintaining constant \Sigma / Q (flow rate) for equivalent recovery.^[43] Filtration follows or complements centrifugation, with dead-end filtration suitable for low-solids feeds where particles accumulate on the filter surface, governed by Darcy's law \frac{dV}{dt} = \frac{A \Delta P}{\mu (\alpha c V / A + R_m)} (A: area, ΔP: pressure drop, μ: viscosity, α: specific cake resistance, c: solids concentration, R_m: medium resistance), but prone to fouling; tangential flow filtration (TFF), or cross-flow, mitigates this by parallel feed flow to the membrane, enabling continuous operation for microfiltration (0.1-10 μm pores) or ultrafiltration (1-100 nm).^[44] Chromatography provides high-resolution purification based on differential interactions, with adsorption isotherms like the Langmuir model describing binding equilibrium as q = \frac{q_{\max} C}{K_d + C}, where q is adsorbed amount, C is equilibrium concentration, q_max is maximum capacity, and K_d is dissociation constant, commonly applied in ion-exchange or affinity modes for proteins achieving >95% purity in steps. Extraction and precipitation methods offer cost-effective initial purification for soluble products. Solvent extraction partitions proteins between immiscible phases, leveraging hydrophobicity differences, as in aqueous two-phase systems (e.g., PEG/dextran) that achieve 80-90% recovery for enzymes with partition coefficients >10.^[45] Precipitation, such as ammonium sulfate salting-out, reduces protein solubility by increasing ionic strength, enabling selective fractionation; for instance, 40-60% saturation often precipitates globulins while leaving albumins soluble, with recoveries up to 85% followed by centrifugation or filtration. Membrane processes like ultrafiltration concentrate macromolecules (MWCO 1-100 kDa) via size exclusion, while diafiltration exchanges buffer through multiple volume replacements to remove salts or small impurities, typically achieving >99% desalting in 5-10 diavolumes with minimal product loss (<5%).^[46] Purification faces significant challenges, including product instability (e.g., enzymatic degradation or aggregation during prolonged exposure) and endotoxin removal, often requiring anion-exchange chromatography or hydrophobic interaction to reduce levels below 0.1 EU/mg for injectables. Validation for Good Manufacturing Practice (GMP) compliance demands robust viral clearance, with factors exceeding 10^6 log reduction typically achieved through orthogonal steps like low pH inactivation (>4 logs) and nanofiltration (>6 logs). Scale-up issues arise from increased hold-up volumes in larger equipment (e.g., 10-20% of process volume in chromatography columns) and pressure drops across filters (ΔP scaling with velocity squared), necessitating pilot testing to maintain residence times and shear below critical thresholds.^[47] Integrated process design, such as perfusion systems combining continuous upstream harvest with downstream TFF and chromatography, minimizes batch hold times and improves overall yields by 20-30% through real-time impurity monitoring.^[48] Yield and purity are evaluated using recovery yield = \frac{\text{pure product mass}}{\text{initial mass}} \times 100\%, targeting >70% step yields to ensure economic viability, alongside purity metrics like host cell protein levels <100 ppm.^[49]

Applications

Pharmaceuticals and Biopharmaceuticals

Biochemical engineering plays a pivotal role in the production of pharmaceuticals and biopharmaceuticals by optimizing bioprocesses for the scalable manufacturing of therapeutic molecules, including biologics and small-molecule drugs. This involves integrating upstream fermentation, downstream purification, and formulation strategies to ensure high purity, potency, and safety while meeting regulatory standards. Key advancements have enabled the transition from laboratory-scale synthesis to industrial production, addressing challenges such as cell line development, bioreactor design, and process intensification to achieve economically viable yields. Monoclonal antibodies (mAbs), essential for treating cancers, autoimmune diseases, and infectious conditions, are predominantly produced using Chinese hamster ovary (CHO) cells in engineered bioprocesses. These cells are transfected with recombinant DNA to express the target antibody, followed by cultivation in large-scale bioreactors where nutrient feeding and waste removal are controlled to maximize productivity. Perfusion bioreactors, which continuously supply fresh media and remove spent media via cell retention devices like alternating tangential flow filters, maintain high cell densities (up to 10^8 cells/mL) and support prolonged production phases, achieving integrated titers of 5-10 g/L or higher through intensified processes.^[50]^[51] This approach contrasts with traditional fed-batch methods, offering higher space-time yields (e.g., >1 g/L/day) and reduced facility footprint for commercial-scale output exceeding hundreds of kilograms per batch.^[52] Vaccine manufacturing leverages biochemical engineering for the production of viral vector systems, particularly adeno-associated virus (AAV) vectors used in gene therapy vaccines to deliver therapeutic genes for conditions like hemophilia and spinal muscular atrophy. AAV production involves transient transfection of HEK293 cells in suspension bioreactors with plasmids encoding the vector components, followed by cell lysis to harvest viral particles, which are then purified via chromatography and ultrafiltration to achieve high vector genomes per milliliter (typically 10^12-10^14 vg/L).^[53]^[54] For certain viral vaccines, inactivation steps using chemicals like beta-propiolactone or formaldehyde ensure pathogen safety while preserving immunogenicity, integrated with downstream tangential flow filtration to remove residuals. Adjuvant formulation, such as aluminum salts or oil-in-water emulsions, enhances immune response by stabilizing antigens and promoting dendritic cell activation during final filling into multidose vials under aseptic conditions.^[55]^[56] Small-molecule drugs, including statins for cholesterol management, are synthesized via microbial fermentation using fungi like Aspergillus terreus, which naturally produces lovastatin through polyketide synthase pathways in submerged bioreactors. The process involves inoculation of spores into nutrient-rich media (e.g., glucose and soybean flour), aeration at 25-30°C for 7-14 days, and extraction of the fermented broth to isolate the active pharmaceutical ingredient (API). Yields are optimized to 1-2 g/L via strain engineering and fed-batch strategies, followed by API crystallization from organic solvents to achieve >99% purity and control polymorph forms for bioavailability.^[57]^[58] Sterile filling then encapsulates the crystallized API into vials or tablets under ISO 5 cleanrooms, employing robotic systems to minimize contamination risks and ensure compliance with good manufacturing practices.^[59]^[60] Regulatory frameworks in biochemical engineering emphasize Process Analytical Technology (PAT) for real-time monitoring of critical process parameters like pH, dissolved oxygen, and metabolite levels using in-line sensors (e.g., Raman spectroscopy and near-infrared probes) to enable immediate adjustments and reduce variability.^[61] Complementing this, Quality by Design (QbD) principles guide process development by identifying critical quality attributes (e.g., glycan profiles for mAbs) through risk assessments and design spaces, ensuring product robustness across scales as endorsed by FDA guidelines.^[62] These tools have facilitated the approval of over 100 biopharmaceuticals by integrating data analytics for predictive control. A notable case study is the rapid scale-up of the Pfizer-BioNTech mRNA COVID-19 vaccine (BNT162b2), which progressed from preclinical lipid nanoparticle encapsulation in 2020 to producing over 3 billion doses by 2021 through parallel bioreactor campaigns and modular purification trains. Biochemical engineers optimized in vitro transcription and enzymatic capping in WAVE bioreactors, achieving >95% encapsulation efficiency, while downstream tangential flow diafiltration removed impurities at yields of 50-70%, demonstrating the agility of engineered processes in pandemic response.^[63] This effort highlighted the integration of single-use technologies to accelerate from lab (grams) to global supply (tons) without compromising sterility or stability.

Food and Agricultural Products

Biochemical engineering plays a pivotal role in the production of enzymes for food processing, where microbial fermentation techniques enable the scalable manufacture of biocatalysts that enhance texture, flavor, and nutritional quality in various products. For instance, α-amylases, derived from fungi like Aspergillus oryzae, are widely used in baking to break down starches into fermentable sugars, improving dough handling and bread volume. These enzymes are typically produced through submerged fermentation, achieving yields up to 770 U/mL under optimized conditions such as controlled pH, temperature, and carbon-nitrogen ratios in laboratory-scale bioreactors.^[64] This process involves inoculating nutrient media with microbial spores and maintaining aerobic conditions to maximize enzyme secretion, with downstream recovery via filtration and purification to meet food-grade standards. Similar engineering approaches apply to other food enzymes, such as proteases for cheese ripening and lipases for flavor development in dairy, ensuring consistent performance in industrial applications. Fermentation processes engineered for traditional foods exemplify biochemical optimization to control microbial metabolism and generate desirable compounds. In yogurt production, lactic acid bacteria like Lactobacillus bulgaricus and Streptococcus thermophilus are cultivated in milk under controlled temperature and pH to convert lactose into lactic acid, yielding a product with improved texture and probiotic benefits.^[65] Beer brewing relies on Saccharomyces cerevisiae to ferment barley-derived sugars into ethanol and carbon dioxide, with process engineering focusing on bioreactor design, yeast strain selection, and temperature profiling to optimize flavor profiles, such as ester and higher alcohol formation, achieving ethanol concentrations of 4-6% v/v. Soy sauce fermentation integrates koji mold (Aspergillus oryzae) for saccharification followed by brine fermentation with halophilic yeasts and bacteria, where biochemical monitoring of amino acid and volatile compound production enhances umami and aroma. These optimizations often employ fed-batch strategies and genetic strain improvements to boost yields and consistency.^[66] In agricultural biotechnology, biochemical engineering facilitates the development of biofertilizers and biopesticides to promote sustainable crop production. Biofertilizers incorporating plant growth-promoting rhizobacteria (PGPR), such as Rhizobium and Azospirillum species, are produced via liquid or solid-state fermentation to fix atmospheric nitrogen and solubilize phosphates, enhancing nutrient availability for legumes and cereals. These formulations, scaled in bioreactors with optimized aeration and nutrient feeds, can increase crop yields by 10-30% while reducing chemical fertilizer use. Biopesticides based on Bacillus thuringiensis produce Cry toxins during sporulation in submerged fermentation, forming crystalline inclusions toxic to lepidopteran pests upon ingestion; engineered strains achieve toxin yields sufficient for commercial sprays that control insects in crops like cotton and maize with minimal environmental impact.^[67]^[68] Waste valorization through biochemical engineering transforms food byproducts into valuable proteins, mitigating environmental burdens from agro-industrial residues. Solid-state fermentation (SSF) utilizes fungi like Aspergillus niger or Rhizopus oryzae on substrates such as wheat bran or fruit peels, promoting mycelial growth and extracellular enzyme secretion to hydrolyze lignocellulosic materials into microbial biomass rich in single-cell proteins. This process, conducted in tray or packed-bed bioreactors at 30-40°C and high humidity, can convert up to 70% of dry matter into protein content exceeding 40% on a dry basis, suitable for animal feed or human nutrition supplements. Engineering aspects include moisture control and aeration to prevent overheating, enabling efficient upcycling of wastes like spent grains from brewing or peels from juice processing.^[69] Ensuring safety and nutritional enhancement in these products involves rigorous biochemical engineering protocols. The Hazard Analysis and Critical Control Points (HACCP) system is integrated into bioprocess design to identify and mitigate microbial hazards, such as pathogen contamination in fermentation vats, through monitoring critical points like temperature and pH to maintain sterility and prevent spoilage.^[70] Nutritional fortification engineering employs bioreactor strategies to incorporate micronutrients, such as iron or vitamins, during microbial growth or post-processing, using encapsulation techniques to stabilize bioactives in fortified foods like fermented dairy or baked goods, thereby addressing deficiencies without altering sensory attributes.^[71] These approaches underscore the discipline's commitment to safe, nutrient-dense food and agricultural outputs.

Bioenergy and Environmental Engineering

Biochemical engineering plays a pivotal role in bioenergy production by leveraging microbial and enzymatic processes to convert renewable biomass into fuels, addressing the demand for sustainable alternatives to fossil fuels. Key advancements include the development of efficient bioconversion pathways that integrate pretreatment, hydrolysis, and fermentation steps to maximize yields while minimizing energy inputs. These processes not only generate biofuels but also contribute to environmental engineering through waste valorization and pollutant degradation, promoting a transition toward circular resource utilization. In biofuel production, lignocellulosic ethanol exemplifies biochemical engineering's impact, where agricultural residues like corn stover or switchgrass undergo pretreatment—such as dilute acid or steam explosion—to disrupt the recalcitrant structure of lignin, hemicellulose, and cellulose, followed by enzymatic hydrolysis to release fermentable sugars, and finally fermentation using engineered strains of Saccharomyces cerevisiae. This integrated approach achieves ethanol yields of approximately 300–400 L per metric ton of dry biomass, with robust strains like SXA-R2P-E attaining 0.43–0.46 g ethanol per g of sugar in pretreated hydrolysates without detoxification. Similarly, biodiesel production from algal biomass harnesses biochemical engineering to cultivate lipid-rich microalgae, such as Chlorella or Scenedesmus species, in photobioreactors, followed by lipid extraction and transesterification, yielding up to 50–70% lipid content by dry weight and reducing reliance on terrestrial crops. Biogas production via anaerobic digestion further demonstrates these principles, where mixed microbial consortia in digesters break down organic wastes like manure or food scraps, producing methane at yields around 0.35 m³ per kg of volatile solids, with biogas composition typically 55–65% CH₄. Complementing this, microbial fuel cells (MFCs) generate electricity directly from wastewater by employing electrogenic bacteria, such as Geobacter species, at the anode to oxidize organics, achieving up to 50% chemical oxygen demand removal while producing power densities of 0.1–1 W/m². Environmental engineering applications of biochemical engineering focus on remediation and treatment using tailored biological systems. Bioremediation employs hydrocarbon-degrading microbes like Pseudomonas species to address oil spills, where bioaugmentation with strains such as P. aeruginosa or P. putida facilitates the breakdown of total petroleum hydrocarbons at rates of 50–90%, as seen in consortium treatments achieving 58–86% degradation over 8–16 days in contaminated soils or marine environments. In wastewater treatment, the activated sludge process relies on aerobic microbial flocs maintained at mixed liquor suspended solids (MLSS) concentrations of 2000–4000 mg/L to achieve efficient organic matter removal, with sludge retention times optimized for nitrification and denitrification to meet effluent standards. Sustainability in these fields is evaluated through life-cycle assessments (LCAs), which quantify carbon footprint reductions; for instance, biodiesel from soy or algal sources can lower greenhouse gas emissions by 40–69% compared to petroleum diesel, factoring in cultivation, processing, and land-use changes. Biochemical engineering also supports circular economy principles in bio-based plastics, where microbial fermentation produces biopolymers like polyhydroxyalkanoates from waste feedstocks, enabling biodegradation or recycling that closes material loops and minimizes plastic pollution. Recent advances, particularly in the 2010s, have utilized synthetic biology to engineer enhanced lignocellulases, such as multifunctional enzyme cocktails incorporating cellulases and hemicellulases from fungi like Trichoderma reesei, boosting hydrolysis efficiency by 2–5 fold through directed evolution and pathway optimization for consolidated bioprocessing.

Education and Professional Practice

Academic Programs and Curriculum

Biochemical engineering academic programs are offered at the bachelor's, master's, and doctoral levels, typically under departments of chemical engineering, bioengineering, or dedicated biochemical engineering units. Bachelor's degrees, such as the Bachelor of Science (BS) in Biochemical Engineering, are commonly structured as four-year programs requiring 120-130 credit hours, integrating foundational sciences with engineering principles to prepare students for bioprocess design and analysis. Master's programs (MS) and Doctor of Philosophy (PhD) degrees build on this foundation, emphasizing advanced research in bioprocess optimization and typically spanning 1-2 years for the MS and 3-5 years for the PhD, often without a strict credit minimum but focused on thesis work.^[2]^[72]^[73] Core curricula in these programs emphasize biological and engineering fundamentals, including courses in microbiology, biochemistry, transport phenomena (such as fluid mechanics and mass transfer), bioprocess kinetics, and bioreactor design. Laboratory components are integral, providing hands-on experience in fermentation processes, microbial culturing, and analytical techniques like chromatography and spectroscopy to develop skills in bioproduct isolation and scale-up. These elements ensure graduates can model and control biological reactions in industrial contexts.^[2]^[74]^[75] Interdisciplinary requirements draw from biology (covering cell metabolism and genetics), chemistry (organic and analytical methods), and core engineering topics (thermodynamics and fluid dynamics), fostering a holistic approach to bioprocess engineering. Students often engage with simulation software, such as Aspen Plus, for modeling bioreactor operations and process flowsheets, enhancing computational proficiency alongside experimental work. This integration prepares learners to address complex bio-systems that span multiple disciplines.^[76]^[74]^[72] In the United States, programs are accredited by ABET under criteria for chemical, biochemical, and similarly named engineering disciplines, which mandate student outcomes in design projects, ethical considerations, and lifelong learning, with a growing emphasis on sustainability in bioprocessing and bioinformatics for genomic data analysis. ABET accreditation ensures curricula include at least one year of engineering topics and incorporate biology, chemistry, and mathematics, often through capstone projects simulating real-world bioprocess challenges. Globally, variations exist; in the European Union, the Bologna Process standardizes degrees into a three-year bachelor's followed by a two-year master's, promoting mobility and integration of biochemical engineering within broader chemical engineering frameworks, contrasting with the U.S. model's deeper specialization in undergraduate tracks.^[77]^[78]^[79]^[80]

Career Opportunities and Challenges

Biochemical engineers pursue diverse professional roles that leverage their expertise in integrating biological processes with engineering principles. Common positions include bioprocess engineers, who design and optimize production plants for biologics and biofuels; research and development (R&D) scientists focused on strain engineering to enhance microbial yields; and regulatory specialists handling submissions to agencies like the U.S. Food and Drug Administration (FDA) for product approval.^[81]^[82] The median annual salary for biochemical engineers, akin to bioengineers, stands at approximately $107,000 USD as of 2025 data.^[83] Employment opportunities span multiple industries, with the largest shares in professional, scientific, and technical services (including biotechnology), accounting for about 23% of roles, and manufacturing (including pharmaceuticals at about 9%), also about 23%, due to demand for biomanufacturing. Employment in food processing is around 1% through fermentation-based products, and in bioenergy sectors less than 2% via sustainable fuel production.^[84] Professionals often work in startups specializing in synthetic biology, such as those developing novel enzymes, contrasted with multinational corporations like Genentech, where large-scale biopharmaceutical operations predominate.^[81] Essential skills for success include proficiency in Good Manufacturing Practice (GMP) compliance to ensure product safety and quality, expertise in scale-up techniques to transition lab processes to industrial levels, and data analysis using artificial intelligence (AI) and machine learning (ML) for real-time bioprocess control and optimization.^[85]^[86] Valuable certifications, such as Six Sigma for process improvement, further enhance employability by demonstrating efficiency in reducing variability.^[87] Despite these opportunities, biochemical engineers face notable challenges, including the high R&D costs for developing new biologics, often ranging from $1-2 billion per asset due to extensive clinical trials and manufacturing complexities.^[88] Talent shortages persist in bioinformatics, where demand for interdisciplinary experts in genomic data handling outpaces supply, exacerbating hiring difficulties in biotech firms.^[89] Ethical concerns surrounding genetically modified organisms (GMOs), such as potential environmental impacts and public health risks from unintended gene flow, also require careful navigation in regulatory and societal contexts.^[90] Looking ahead, the field anticipates robust demand growth projected to grow 5 percent from 2024 to 2034, faster than the average for all occupations, propelled by advancements in personalized medicine for tailored therapies and green technologies for eco-friendly bioprocessing.^[81]^[91] These trends underscore the evolving role of biochemical engineers in addressing global health and sustainability needs.^[3]

References

[1]
Biochemical Engineering - an overview | ScienceDirect Topics
Biochemical engineering is defined as a branch of biochemistry engineering that focuses on the commercialization of biotechnology by applying principles of ...
[2]
BS Biochemical Engineering - College of Engineering
Combine the principles of biology, chemistry and engineering to develop high-value products from biochemical processes for a variety of applications ...
[3]
The Importance and Future of Biochemical Engineering - PMC
A critical future goal of the biochemical and molecular engineering community will be the investigation, development, and engineering of non-model cells, ...
[4]
Biochemical Engineering - an overview | ScienceDirect Topics
Biochemical engineering involves the application of chemical engineering principles to biological systems and the manufacture of biologically derived products ...
[5]
BIOCHEMICAL ENGINEERING - Thermopedia
Biochemical engineering is usually defined as the extension of chemical engineering principles to systems using a biological catalyst to bring about desired ...
[6]
What is Biochemical Engineering? - University College London
Biology is amazing at transforming one chemical to another, Biochemical Engineering is the harnessing of this process to make products on an industrial scale.
[7]
Monod Equation - an overview | ScienceDirect Topics
where μ is the specific growth rate of the microorganisms (defined as μ = dX dt 1 X ), μmax is the maximum specific growth rate of the microorganisms, S is the ...
[8]
Biomass Yield - an overview | ScienceDirect Topics
The true yield YXS is limited by stoichiometric considerations. However, from Eq. (12.111), Y ΄ XS can be improved by decreasing the maintenance coefficient.
[9]
Maintenance Coefficient - an overview | ScienceDirect Topics
The maintenance coefficient is defined as the fraction of total substrate flux that is allocated to maintenance requirements rather than growth, reflecting the ...
[10]
Review The origins of enzyme kinetics - ScienceDirect.com
Sep 2, 2013 · Michaelis and Menten are by far the best known of the scientists who created the subject of enzyme kinetics, but what was their real contribution?Review · 3. Advances Made By Other... · 4. Michaelis And Menten's...
[11]
Michaelis-Menten Kinetics - an overview | ScienceDirect Topics
Michaelis–Menten kinetics is defined as a mathematical framework that describes the rate of an enzymatic reaction based on substrate concentration and enzyme ...
[12]
Estimation of volumetric mass transfer coefficient (kLa)
Mar 15, 2020 · The oxygen transfer rate (OTR) is influenced by the hydrodynamic conditions in a bioreactor that are determined be several parameters including ...
[13]
Aseptic Operation - an overview | ScienceDirect Topics
Aseptic operations are achieved by a combination of a sterile system at the start and the elimination of the potential of biocontaminants during the operations.
[14]
Reflections on the History and Scientific Character of Biochemical ...
Selected historical events in biochemistry, biochemical engineering, and specifically enzyme technology are discussed in the context of science history.
[15]
History of Chemical & Bioprocess Engineering - UCD School of ...
Apr 23, 2024 · Little in 1915 and formed the basis for a classification of chemical engineering that dominated the subject for the next 40 years. The number of ...
[16]
Enzymes: principles and biotechnological applications - PMC
Our final equation, usually called the Michaelis–Menten equation, therefore becomes: Initial rate of reaction ( v 0 ) = V max × Substrate concentration ...
[17]
Industrial production of acetone and butanol by fermentation—100 ...
May 18, 2016 · At this time Chaim Weizmann became involved in the development of this process. He isolated a new bacterial culture, readily fermenting ...
[18]
G. G. Brown: Mentor and pioneer - Chemical Engineering
Jan 22, 2018 · George Granger (GG) Brown was known not only for his intellect, vision, and career accomplishments but also for a few peculiar physical characteristics.
[19]
Penicillin Production through Deep-tank Fermentation
Pfizer succeeded in producing large quantities of penicillin using deep-tank fermentation. Its success helped make penicillin available to Allied soldiers by ...Missing: 100 100000
[20]
Professor Pearce and peers secure Pfizer plant National Historic ...
... Pfizer's deep-tank fermentation process used to produce penicillin lead to advancements in the production of many other drugs throughout the globe. Next ...
[21]
Herbert W. Boyer and Stanley N. Cohen | Science History Institute
Recombinant Insulin and Other Projects In 1982 Humulin was approved by the FDA, and it became the first biotechnology product to appear on the market. Whereas ...A Boyer-Cohen Collaboration · Interspecies Cloning · Recombinant Insulin And...Missing: primary | Show results with:primary
[22]
Science and History of GMOs and Other Food Modification Processes
Mar 5, 2024 · 1973: Biochemists Herbert Boyer and Stanley Cohen develop genetic engineering by inserting DNA from one bacteria into another. 1982: FDA ...Missing: cloning recombinant
[23]
Making, Cloning, and the Expression of Human Insulin Genes ... - NIH
Support from industry and academic collaborators resulted in Food and Drug Administration approval of Humulin in 1982, the first human insulin made by ...
[24]
US4649117A - Air lift bioreactor - Google Patents
The disclosure provides an improved reactor/fermentor apparatus useful for carrying out cell culture and fermentation. The apparatus utilizes novel design ...<|separator|>
[25]
The Advancement in Membrane Bioreactor (MBR) Technology ... - NIH
This article outlines the historical advancement of the MBR process in the treatment of industrial and municipal wastewaters.
[26]
The Human Genome Project: big science transforms biology and ...
Sep 13, 2013 · The Human Genome Project has transformed biology through its integrated big science approach to deciphering a reference human genome sequence.
[27]
Genome engineering using the CRISPR-Cas9 system - PubMed - NIH
Here we describe a set of tools for Cas9-mediated genome editing via nonhomologous end joining (NHEJ) or homology-directed repair (HDR) in mammalian cells.
[28]
https://www1.eere.energy.gov/bioenergy/pdfs/program_accomplishments_report.pdf
[29]
Range Fuels Breaks Ground on the Nations First Commercial ...
Through Range Fuels' innovative process for producing cellulosic ethanol, the Soperton plant will use a quarter of the average water required by ...
[30]
Demonstration of Comparability of Human Biological Products ... - FDA
This document addresses the concept of product comparability and describes current FDA practice concerning product comparability of human biological products.
[31]
Chapter 10. Upstream Bioprocess – Microbial Biotechnology
This phase also includes the preparation of starter cultures (inoculum), the development of nutrient-rich media with carbon and nitrogen sources, and the ...10.3. Media Formulation And... · 10.5. Inoculum Development · 10.7. Environmental Control...
[32]
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/demonstration-comparability-human-biological-products-including-therapeutic-biotechnology-derived
[33]
Stirred-Tank Bioreactors - an overview | ScienceDirect Topics
CSTR, or continuous stirred-tank reactor, is defined as an ideal reactor where reactants are continuously fed and products are simultaneously removed, ...Missing: fluidized- criteria
[34]
Bioreactor Configuration - an overview | ScienceDirect Topics
The basic bioreactor configurations discussed above for heterotrophic growth (ie, stirred tanks, bubble columns and airlift bioreactors, packed and fluidized ...Missing: criteria | Show results with:criteria
[35]
Fluid Flow and Mixing With Bioreactor Scale-Up
Jun 12, 2024 · For most stirred bioreactor systems, the ratio of clearance to fluid height (C/H L) typically falls into the range of 0.33–0.66 (3). Impeller ...Missing: CSTR bed
[36]
Controlling the key parameters of a bioreactor - Cytiva
The level of dissolved oxygen (DO) is monitored by a sensor. Most mammalian cell cultures are performed with a DO of around 20%–50% of the saturation with air.Missing: monitoring biomass
[37]
Optimizing the strain engineering process for industrial-scale ...
Typically, strain engineering for recombinant protein production involves improving protein expression by introducing extra copies of the protein-encoding gene ...
[38]
Downstream Processing - an overview | ScienceDirect Topics
Downstream processing refers to the series of unit operations used to isolate, purify, and concentrate the product. Downstream processing often determines the ...
[39]
Downstream Processing in Biopharmaceuticals | Steps & Instruments
With depth filtration, a particle-containing mixture is pumped through a membrane or another interface to separate debris from the product in liquid suspension.
[40]
Addressing the Challenges in Downstream Processing Today and ...
Increasing upstream titers and shrinking development timelines have posed several challenges to downstream process development of mAbs.
[41]
[PDF] Downstream Processing (Textbook Chapter 11 & Supplemental ...
Nov 27, 2017 · Topics. Downstream processing needed to separate cell mass & other byproducts from the water solvent. Major categories.
[42]
[PDF] Chapter 11: Downstream Processing - Biomanufacturing.org
Microfiltration can be used at the start of the downstream process to clarify the feed beyond what was accomplished in the upstream harvest and centrifugation/ ...
[43]
Upstream and Downstream Bioprocessing in Enzyme Technology
Dec 27, 2023 · Downstream processing ensures the efficient recovery of commercially viable products. These processes in enzymatic systems consist of ...
[44]
New developments in membranes for bioprocessing – A review
Feb 15, 2021 · This Review examines how the membrane industry has responded to these challenges, with a focus on recent developments in membranes, modules, and processes.
[45]
Risks and Control Strategies of Scale-up in Purification Process
Scale-up risks include material issues, process selection, equipment differences, and practical constraints. Tools like GAP analysis and FMEA are recommended ...
[46]
Current Challenges in Bioprocesses Development
Mar 2, 2018 · Bioprocessing professionals clearly see a number operational problems remaining with upstream perfusion versus conventional batch processing.
[47]
Towards a better process outcome - Cytiva
Sep 11, 2024 · So, the titer characterizes the upstream bioprocessing efficiency, while the yield refers to the downstream efficiency. Although high titers ...
[48]
Trends in Monoclonal Antibody Production Using Various Bioreactor ...
This review describes recent trends in high-density cell culture systems established for monoclonal antibody production that are excellent methods to scale up.
[49]
Scaling Fed-Batch and Perfusion Antibody Production Processes in ...
Apr 17, 2024 · Based on the bioreactor volume, such perfusion processes can produce more than 1 g L−1 d−1 of mAbs [7,8]. Depending on the cell line used and ...
[50]
Enhancing and stabilizing monoclonal antibody production by ...
Jan 19, 2023 · This study provided some guidance for the high-efficient production of monoclonal antibody by CHO cells via optimized perfusion culture strategy.Abstract · Introduction · Materials and methods · Results and discussion
[51]
Adeno-associated virus vector as a platform for gene therapy delivery
Abstract. Adeno-associated virus (AAV) vectors are the leading platform for gene delivery for the treatment of a variety of human diseases.Missing: formulation | Show results with:formulation
[52]
AAV Gene Therapy Manufacturing Process - Creative Diagnostics
The basic mechanical technique for releasing AAV vectors from cells is repeated freezing/thawing followed by low-speed centrifugation steps. However, this ...Upstream Cultivation · Downstream Purification · Final Formulation
[53]
[PDF] Chemistry, Manufacturing, and Control Information for Human Gene ...
For non-replicating gene therapy viral vectors, we recommend specific testing, due to the potential for these vectors to recombine or revert to a parental ...
[54]
[PDF] Vaccine Technologies and Platforms for Infectious Diseases
Dec 16, 2021 · Vaccines can be manufactured under multiple forms including, inactivated (killed), toxoid, live attenuated, Virus-like Particles, synthetic.
[55]
Exploitation of Aspergillus terreus for the Production of Natural Statins
Here we review the discovery of statins, along with strategies that have been applied to scale up their production by A. terreus strains.Missing: API crystallization sterile filling
[56]
Lovastatin production by an oleaginous fungus, Aspergillus terreus ...
Feb 14, 2022 · Lovastatin is produced using different fermentation strategies, including surface fermentation, solid-state fermentation (SSF), and submerged ...
[57]
Sterile API Manufacturing - Curia Global
Stage one: dissolution and sterile filtration. · Stage two: crystallization. · Stage three: filtration and drying. · Stage four: physical treatment and packaging.
[58]
Expanding Sterile Crystallization Capabilities to Meet Rising ...
Dec 20, 2019 · Sterile crystallization involves the conversion of non-sterile drug substances to sterile APIs. The non-sterile compound is charged into a non- ...
[59]
[PDF] FDA Guidance for Industry PAT – A Framework for Innovative ...
This guidance is intended to describe a regulatory framework (Process Analytical Technology,. PAT) that will encourage the voluntary development and ...
[60]
[PDF] Q8(R2) Pharmaceutical Development - FDA
guidance and describes the principles of quality by design (QbD). ... experimental designs, process analytical technology (PAT), and/or prior knowledge.
[61]
Delivering 3 billion doses of Comirnaty in 2021 | Nature Biotechnology
Feb 2, 2023 · Pfizer and BioNTech advanced Comirnaty from research to product, gaining authorization in December 2020 and manufacturing 3 billion doses by the end of 2021.
[62]
Optimization of submerged Aspergillus oryzae S2 α-amylase ... - NIH
Laboratory scale application of optimal conditions in a 7 L fermentor produced a final α-amylase activity of 770 U/mL after 3 days of batch cultivation.
[63]
Fermentative Foods: Microbiology, Biochemistry, Potential Human ...
Most of the well-known soy-based fermented foods from Asia, such as tempeh and soy sauce, are produced by fungal fermentation, except natto, which is produced ...
[64]
Advances in genetically engineered microorganisms: Transforming ...
This review explores the advancements in precision fermentation, highlighting the role of synthetic biology and protein engineering in the production of ...
[65]
Bacillus thuringiensis as microbial biopesticide: uses and ...
Jun 19, 2021 · The present review briefly provides an overview of the Bt uses and application as a biocontrol agent against insect pest for sustainable agriculture.
[66]
Plant growth-promoting rhizobacterial biofertilizers for crop production
Sep 16, 2022 · Biofertilizers are microbial formulations constituted of indigenous plant growth-promoting rhizobacteria (PGPR) that directly or indirectly ...
[67]
Valorization of agro-industrial waste through solid-state fermentation
This review discusses the factors affecting the production of value-added products through solid state fermentation.
[68]
HACCP Principles & Application Guidelines - FDA
Feb 25, 2022 · HACCP is a management system in which food safety is addressed through the analysis and control of biological, chemical, and physical hazards ...Missing: biochemical fortification
[69]
Engineering strategies for food fortification - ScienceDirect.com
This opinion paper discusses how process engineering can be used for food fortification. The time of food processing can be utilized to incorporate nutrients ...Missing: biochemical | Show results with:biochemical
[70]
Chemical Engineering, Biochemical Engineering Emphasis (BS)
The requirement for the Bachelor of Science in Chemical Engineering with an emphasis in Biochemical Engineering is 133 units.Missing: curriculum | Show results with:curriculum
[71]
Chemical & Biochemical Engineering | Rutgers School of Graduate ...
The graduate program in Chemical and Biochemical Engineering provides a range of unique opportunities for advanced training and research.
[72]
Curriculum for the Biochemical Engineering Concentration
The Chemical Engineering degree requires at least 2 engineering technical electives. Advanced Biochem and Bio courses fulfill non-engineering tech electives.Missing: bachelor's | Show results with:bachelor's
[73]
Biochemical Engineering - Undergraduate Majors and Minors
Possible Career Directions: Pharmaceutics, manufacturing, vaccine development, medicine, quality control · Courses: Organic Chemistry; Bio-transport Phenomena; ...Biochemical Option · Minor In Biomedical... · Minor Requirements
[74]
CBE Undergraduate Curriculum
Chemical Engineering Curriculum, Biochemical Engineering Curriculum, Courses, Technical Electives, Undergraduate Handbook, Specialized Tracks.
[75]
Criteria for Accrediting Engineering Programs, 2025 - 2026 - ABET
The curriculum must include experience in: Applying principles of engineering, biology, human physiology, chemistry, calculus-based physics, mathematics ( ...Criterion 3. Student Outcomes · Criterion 5. Curriculum · Criterion 6. Faculty
[76]
Biochemical Engineering (BS)
Oct 25, 2024 · The Biochemical Engineering (BS) program is accredited by the Engineering Accreditation Commission of ABET under the commission's General Criteria and Program ...
[77]
Accreditation
The chemical and biochemical engineering program is accredited by the Engineering Accreditation Commission of ABET. The Chemical Engineering (B.S.) degree ...
[78]
Bologna Recommendations
Therefore in a number of countries in Europe we can distinguish two types of higher education in chemical engineering: "more research-oriented" first cycle (" ...Missing: biochemical | Show results with:biochemical
[79]
Bioengineers and Biomedical Engineers - Bureau of Labor Statistics
Bioengineers and biomedical engineers combine engineering principles with sciences to design and create equipment, devices, computer systems, and software.<|control11|><|separator|>
[80]
What does a Biochemical Engineer do? Career Overview, Roles, Jobs
They use their knowledge of biology, chemistry, and engineering to optimize the production of these products, as well as improve their quality and safety.
[81]
Biochemical Engineer Salary in 2025 | PayScale
The average salary for a Biochemical Engineer is $107647 in 2025. Visit ... MEDIAN. $108k. 90%. $243k. The average salary for a Biochemical Engineer is ...
[82]
Bioengineers and Biomedical Engineers - Bureau of Labor Statistics
Industries with the highest levels of employment in Bioengineers and Biomedical Engineers: Industry, Employment (1), Percent of industry employment, Hourly ...
[83]
Artificial intelligence technologies in bioprocess: Opportunities and ...
AI has been extensively applied in bioprocess modeling and optimization. Convenient, accurate and rapid monitoring technologies are emerging.
[84]
Artificial Intelligence in the Biopharmaceutical Industry
May 10, 2024 · ML applications and AI-enabled DTs improve researchers' and engineers' ability to analyze, model, and control biomanufacturing processes based ...
[85]
How To Become a Biochemical Engineer in 5 Steps (With Tips)
Jun 9, 2025 · A high school diploma, GED or equivalent is often the minimum education level employers look for when hiring biochemical engineers.
[86]
Drug development cost pharma $2.2B per asset in 2024 as GLP-1s ...
Mar 25, 2025 · The average cost for a Big Pharma to develop a drug in 2024 was $2.23 billion, up from $2.12 billion the year before.
[87]
Bioinformatics and genomics: A rapidly expanding field with a ...
Aug 5, 2025 · Bioinformatics and genomics: A rapidly expanding field with a workforce shortage. View organization page for New Scientist Jobs · New Scientist ...
[88]
Ethical arguments relevant to the use of GM crops - ScienceDirect.com
Nov 30, 2010 · Five sets of ethical concerns have been raised about GM crops: potential harm to human health; potential damage to the environment; negative impact on ...Review · Introduction · The Moral ImperativeMissing: biochemical | Show results with:biochemical<|control11|><|separator|>
[89]
Bioengineers and Biomedical Engineers | My Future
About 1,400 openings for bioengineers and biomedical engineers are projected each year, on average, over the decade. Many of those openings are expected to ...Missing: distribution | Show results with:distribution
[90]
10 Life Science and Biotech Trends to Watch in 2025 - Life in the Lab
Mar 21, 2024 · 10 Life Science and Biotech Trends to Watch in 2025 · 1. Personalized medicine and cell therapies · 2. Gene therapies · 3. Lab sustainability · 4.